Dipeptidyl peptidase IV and adenosine deaminase activity decrease in depression

Psychoneuroendocrinology

Volumn 24, Issue 8, 1999, Pages 823-832

  Elgün, Serenay ^a   Keskinege, Aytaç ^a   Kumbasar, Hakan ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b Department of Psychiatry   (Turkey)

Author keywords

Adenosine deaminase; Depression; Dipeptidyl peptidase IV

Indexed keywords

ADENOSINE DEAMINASE; DIPEPTIDYL PEPTIDASE IV;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME REPRESSION; FEMALE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; IMMUNOPATHOGENESIS; MALE; MOLECULAR DYNAMICS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADENOSINE DEAMINASE; ADULT; ANTIGENS, CD26; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; IMMUNE TOLERANCE; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHONEUROIMMUNOLOGY; T-LYMPHOCYTES;

EID: 0032843197     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(99)00039-6     Document Type: Article

References (34)

1. De Meester I., Mertens A.V., De Clerck L.S., Scharpe S., Bridts C.H., Stevens W.J. Correlations between dipeptidyl peptidase IV and disease activity of rheumatoid arthritis. J. Allergy Clin. Immunol. 91:1993;228-232.
2. De Meester I., Vanham G., Kestens L. et al. Binding of adenosine deaminase to the lymphocyte surface via CD26. Eur. J. Immunol. 24:1994;566-570.
3. Dong R-P., Kameoka J., Hegen M. et al. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J. Immunol. 156:1996;1349-1355.
4. First, M.B., Spitzer, R.L., Gibbon, M., Williams J.B.W., 1997. Structured Clinical Interview for DSM-IV Axis I Disorders, Research version, Non-patient Edition. (SCID-I/NP) Biometrics Research, New York State Psychiatric Institute, New York.
5. Franco R., Casado V., Ciruela F. et al. Cell surface adenosine deaminase much more than an ectoenzyme. Prog. Neurobiol. 52:1997;283-294.
6. Frommberger U.H., Bauer J., Haselbauer P., Fraulin A., Rieman D., Berger M. Interleukin-6 (IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur. Arch. Psychiatry Clin. Neurosci. 247:1997;228-233.
7. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6:1967;278-296.
8. Hendriks D., De Meester I., Umiel T. et al. Aminopeptidase P and dipeptidyl peptidase IV activity in human leukocytes and in stimulated lymphocytes. Clin. Chim. Acta. 196:1991;87-96.
9. Hoffmann T., Faust J., Neubert K., Ansorge S. Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences. FEBS Lett. 336:1993;61-64.
10. Jeanfavre D.D., Woska Jr J.R., Pargellis C.A. et al. Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase. Biochem. Pharmacol. 13:1996;1757-1765.
11. Kameoka J., Tanaka T., Nojima Y., Schlossman S.F., Morimoto C. Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science. 261:1993;466-469.
12. Kasahara Y., Leroux-Roels G., Nakamura R., Chisari F. Glycylprolyl-diaminopeptidase in human leukocytes: selective occurrence in T lymphocytes and influence on the total serum enzyme activity. Clin. Chim. Acta. 139:1984;295-302.
13. Lokshina L.A. Plasma membrane proteases from lymphoid cells and their biological functions. Bioorg. Khim. 24:1998;323-331.
14. Maes M., Bosmans E., Suy E., Minner B., Raus J. A further exploration of the relationships between immune parameters and the HPA-axis activity in depressed patients. Psychol. Med. 21:1991;313-320.
15. Maes M., De Meester I., Vanhoof G. et al. Decreased serum dipeptidyl peptidase IV activity in major depression. Biol. Psychiatry. 30:1991;577-586.
16. Maes M., De Meester I., Scharpe S., Desnyder R, Ranjan R., Meltzer H.Y. Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs. Acta Psychiatr. Scand. 93:1996;1-8.
17. Maes M., De Meester I., Verkerk R. et al. Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: relationships with immune-inflammatory markers. Psychoneuroendocrinology. 22:1997;65-78.
18. Maes M., Meltzer H., Jacobs J. et al. Autoimmunity in depression: increased antiphospholipid autoantibodies. Acta Psychiatr. Scand. 87:1993;160-166.
19. Maes M., Scharpe S., Van Grootel L. et al. Higher alpha 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness. J. Affect. Disord. 24:1992;183-192.
20. Morimoto C., Schlossman S.F. The structure and function of CD26 in the T-cell immune response. Immunol. Rev. 161:1998;55-70.
21. Nagatsu T., Hino M., Fuyamada H. et al. New chromogenic substrates for x-prolyl dipeptidyl-aminopeptidase. Anal. Biochem. 74:1976;466-476.
22. Nagy J.I., Yamamoto T., Uemura H., Schrader W.P. Adenosine deaminase in rodent median eminence: detection by antibody to the mouse enzyme and co-localization with adenosinedeaminase-complexing protein (CD26). Neuroscience. 73:1996;459-471.
23. Nilius R., Stuhec K., Dietrich R. Changes of dipeptidyl peptidase IV as a membrane marker of lymphocytes in acute and chronic liver diseases - biochemical and cytochemical investigations. Physiol. Res. 40:1991;95-102.
24. Oosthuizen H.M., Ungerer J.P.J., Bissbort S.H. Kinetic determination of serum adenosine deaminase. Clin. Chem. 39:1993;2182-2185.
25. Oravecz T., Pall M., Roderiquez G. et al. Regulation of the receptor specificity and the function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J. Exp. Med. 186:1997;1865-1872.
26. Reddy P.L., Khanna S., Subhash M.N., Channabasavanna S.M., Rama Rao B.S.S. CSF amine metabolites in depression. Biol. Psychiatry. 31:1992;112-118.
27. Reinhold D., Bank U., Buhling F. et al. Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells. Immunology. 91:1997;354-360.
28. Robins L.N., Helzer J.E., Croughan J., Ratcliff K.S. The National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics, and validity. Arch. Gen. Psychiatry. 38:1981;381-389.
29. Sanda M.G., Pierson R., Smith C., Reemtsma K., Rose E. Serum dipeptidyl peptidase IV in cardiac transplant recipients. Transplant. Proc. 21:1989;2525-2526.
30. Schleifer S.J., Keller S.E., Meyerson A.T., Raskin M.J., Davis K.L., Stein M. Lymphocyte function in major depressive disorder. Arch. Gen. Psychiatry. 41:1984;484-486.
31. Shibuya-Saruta H., Kasahara Y., Hashimoto Y. Human serum dipeptidyl peptidase IV (DPPIV) and its unique properties. J. Clin. Lab. Anal. 10:1996;435-440.
32. Sluzewska A., Rybakowski J., Bosmans E. et al. Indicators of immune activation in major depression. Psychiatry Res. 64:1996;161-167.
33. Stancikova M., Lojda Z., Lukac J., Ruzickova M. Dipeptidyl peptidase IV in patients with systemic lupus erythematosus. Clin. Exp. Rheumatol. 10:1992;381-385.
34. Vanhoof G., De Meester I., van Sande M., Scharpe S., Yaron A. Distribution of proline-specific aminopeptidases in human tissues and body fluids. Eur. J. Clin. Chem. Clin. Biochem. 30:1992;333-338.